Pacific Biosciences of California, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Pacific Biosciences of California, Inc. (PACB) reported Cost of Goods Sold (Deprecated 2018-01-31) of $9.02 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-02.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-02
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $9.02M, a 20.62% decline year-over-year.
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $11.84M, a 5.27% increase year-over-year.
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $11.55M, a 24.52% increase year-over-year.
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $8.15M, a 14.62% increase year-over-year.
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $42.90M, a 24.30% increase from fiscal 2016.
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $34.51M, a 12.40% increase from fiscal 2015.
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $30.70M, a 3.64% increase from fiscal 2014.
- Pacific Biosciences of California, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $29.63M, a 88.63% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $9.02M 10-Q · filed 2018-05-02 | $20.86M derived: sum of 2 quarters · filed 2018-05-02 | $32.40M derived: sum of 3 quarters · filed 2018-05-02 | $40.56M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-12-31 | $11.84M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $23.38M derived: sum of 2 quarters · filed 2018-02-26 | $31.54M derived: sum of 3 quarters · filed 2018-02-26 | $42.90M 10-K · filed 2018-02-26 |
| 2017-09-30 | $11.55M 10-Q · filed 2017-11-02 | $19.70M derived: sum of 2 quarters · filed 2017-11-02 | $31.06M 10-Q · filed 2017-11-02 | $42.31M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-06-30 | $8.15M 10-Q · filed 2017-08-02 | $19.52M 10-Q · filed 2017-08-02 | $30.76M derived: sum of 3 quarters · filed 2018-05-02 | $40.03M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-03-31 | $11.36M 10-Q · filed 2018-05-02 | $22.61M derived: sum of 2 quarters · filed 2018-05-02 | $31.88M derived: sum of 3 quarters · filed 2018-05-02 | $38.99M derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $11.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $20.52M derived: sum of 2 quarters · filed 2018-02-26 | $27.63M derived: sum of 3 quarters · filed 2018-02-26 | $34.51M 10-K · filed 2018-02-26 |
| 2016-09-30 | $9.27M 10-Q · filed 2017-11-02 | $16.39M derived: sum of 2 quarters · filed 2017-11-02 | $23.27M 10-Q · filed 2017-11-02 | $30.68M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $7.12M 10-Q · filed 2017-08-02 | $13.99M 10-Q · filed 2017-08-02 | $21.41M derived: sum of 3 quarters · filed 2018-02-26 | $26.53M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $6.88M 10-Q · filed 2017-05-05 | $14.29M derived: sum of 2 quarters · filed 2018-02-26 | $19.41M derived: sum of 3 quarters · filed 2018-02-26 | $27.85M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $12.53M derived: sum of 2 quarters · filed 2018-02-26 | $20.97M derived: sum of 3 quarters · filed 2018-02-26 | $30.70M 10-K · filed 2018-02-26 |
| 2015-09-30 | $5.12M 10-Q · filed 2016-11-04 | $13.56M derived: sum of 2 quarters · filed 2016-11-04 | $23.29M 10-Q · filed 2016-11-04 | $33.87M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $8.44M 10-Q · filed 2016-08-04 | $18.17M 10-Q · filed 2016-08-04 | $28.75M derived: sum of 3 quarters · filed 2017-03-06 | $34.36M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $9.73M 10-Q · filed 2016-05-05 | $20.31M derived: sum of 2 quarters · filed 2017-03-06 | $25.92M derived: sum of 3 quarters · filed 2017-03-06 | $32.19M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $10.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $16.19M derived: sum of 2 quarters · filed 2017-03-06 | $22.46M derived: sum of 3 quarters · filed 2017-03-06 | $29.63M 10-K · filed 2017-03-06 |
| 2014-09-30 | $5.61M 10-Q · filed 2015-11-05 | $11.88M derived: sum of 2 quarters · filed 2015-11-05 | $19.05M 10-Q · filed 2015-11-05 | $23.62M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $6.27M 10-Q · filed 2015-08-05 | $13.44M 10-Q · filed 2015-08-05 | $18.01M derived: sum of 3 quarters · filed 2016-03-11 | $22.62M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $7.17M 10-Q · filed 2015-05-05 | $11.74M derived: sum of 2 quarters · filed 2016-03-11 | $16.35M derived: sum of 3 quarters · filed 2016-03-11 | $19.68M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $9.18M derived: sum of 2 quarters · filed 2016-03-11 | $12.51M derived: sum of 3 quarters · filed 2016-03-11 | $15.71M 10-K · filed 2016-03-11 |
| 2013-09-30 | $4.62M 10-Q · filed 2014-11-05 | $7.94M derived: sum of 2 quarters · filed 2014-11-05 | $11.14M 10-Q · filed 2014-11-05 | $14.98M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $3.32M 10-Q · filed 2014-08-05 | $6.52M 10-Q · filed 2014-08-05 | $10.37M derived: sum of 3 quarters · filed 2015-03-12 | $11.33M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $3.20M 10-Q · filed 2014-05-08 | $7.05M derived: sum of 2 quarters · filed 2015-03-12 | $8.01M derived: sum of 3 quarters · filed 2015-03-12 | $13.39M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.81M derived: sum of 2 quarters · filed 2015-03-12 | $10.19M derived: sum of 3 quarters · filed 2015-03-12 | $18.80M 10-K · filed 2015-03-12 |
| 2012-09-30 | $960.00K 10-Q · filed 2013-11-12 | $6.34M derived: sum of 2 quarters · filed 2013-11-12 | $14.95M 10-Q · filed 2013-11-12 | $24.59M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $5.38M 10-Q · filed 2013-08-09 | $13.99M 10-Q · filed 2013-08-09 | $23.63M derived: sum of 3 quarters · filed 2014-03-14 | $30.18M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $8.61M 10-Q · filed 2013-05-10 | $18.25M derived: sum of 2 quarters · filed 2014-03-14 | $24.80M derived: sum of 3 quarters · filed 2014-03-14 | $27.33M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $16.19M derived: sum of 2 quarters · filed 2014-03-14 | $18.73M derived: sum of 3 quarters · filed 2014-03-14 | $18.73M 10-K · filed 2014-03-14 |
| 2011-09-30 | $6.55M 10-Q · filed 2012-11-01 | $9.08M derived: sum of 2 quarters · filed 2012-11-01 | $9.08M 10-Q · filed 2012-11-01 | |
| 2011-06-30 | $2.54M 10-Q · filed 2012-08-07 | $2.54M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |